Organometallics
Article
volume of 0.6 mL) was injected outside the glovebox using gastight
syringes in the flow of argon upon appropriate cooling to <0 °C.
Addition of norbornene (4−6 equiv as a 0.45 M solution in
chlorobenzene) to the above sample (if nesessary) was performed at
20 °C, using a gastight syringe.
6H, NCMe); 1.18 (d, 6H, J = 6.6 Hz, CH(CH3)2); 0.95 (d, 6H, J = 6.8
Hz, CH(CH3)2); −0.56 (s, 3H, Ni−CH3); minor conformer, δ 7.69 (t, J
= 7.7 Hz, PyHp); 2.99 (sept, J = 6.7 Hz, CH(CH3)2); 1.71 (s, NCMe);
−0.48 (s, Ni−CH3). 13C NMR (toluene-d8/1,2-difluorobenzene, 10
°C): major conformer, δ 177.47 (NCMe); 149.25 (B(C6F5)4, o-C,
1JFC = 244 Hz); 143.36 (ArC); 141.04 (PyCγ, 1JCH = 170.1 Hz); 140.44
(ArC); 140.26 (B(C6F5)4, p-C, 1JFC = 244 Hz); 137.17 (B(C6F5)4, m-C,
JFC = 244 Hz); 127.15 (ArCH); 121.59 (ArCH, 1JCH = 159.0 Hz); 29.24
1H NMR (toluene-d8/1,2-difluorobenzene, 2 °C): major conformer,
δ 7.77 (dt, 1H, J = 7.8 Hz, PyHp); 7.23 (d, 2H, J = 7.8 Hz, PyHm); 7.09
(d, 2H, J = 7.6 Hz, ArH); 6.47 (t, 2H, J = 7.6 Hz, ArH); 1.89 (s, 3H, N
CMe); −0.39 (s, Ni−CH3); minor conformer, δ 7.77 (dt, 1H, J = 7.8 Hz,
PyHp); 7.23 (d, 2H, J = 7.8 Hz, PyHm); 7.09 (d, 2H, J = 7.6 Hz, ArH);
6.47 (t, 2H, J = 7.6 Hz, ArH); 1.83 (s, 3H, NCMe); −0.44 (s, Ni−
CH3). 13C NMR (toluene-d8/1,2-difluorobenzene, 2 °C): major
1
1
(CH(CH3)2, JCH = 124.9 Hz); 23.79 (CH(CH3)2, JCH = 126.0 Hz);
1
1
22.44 (CH(CH3)2, JCH = 126.0 Hz); 17.32 (NCMe, JCH = 130.6
Hz); 7.17 (Ni−CH3, 1JCH = 129.0 Hz); minor conformer, δ 177.80 (N
CMe); 143.47 (ArC); 127.32 (ArCH); 121.43 (ArCH); 29.05
(CH(CH3)2); 22.62 (CH(CH3)2); 17.46 (NCMe).
1
conformer, δ 179.70 (NCMe); 153.03 (ArCF, JFC = 248.0 Hz);
141.34 (PyCγ, 1JCH = 169.8 Hz); 133.08 (ArC); 130.29 (ArCH); 126.05
X-ray Measurements. X-ray quality crystals of 1b·CH3CN were
grown from CH3CN/EtOAc (1.5/1) upon slow diffusion of Et2O at +4
°C. Single-crystal diffraction data for 1b·CH3CN were collected on a
Bruker X8Apex four-circle diffractometer equipped with an area
detector (Mo Kα, graphite monochromator, φ and ω scans). The
absorption correction was applied on the basis of intensities of
equivalent reflections with the use of the SADABS program.9a The
structure was solved by direct methods and refined anisotropically
(except for the H atoms) by the full-matrix least-squares method using
the SHELX-97 program package.9b The asymmetric unit contains the
complex trans-[Ni(C27H31N3)(CH3CN)Cl2], in which the Ni(II) cation
has a distorted-octahedral coordination environment formed by four
nitrogen atoms of a bis(imino)pyridine ligand and an acetonitrile
molecule in equatorial positions, and two chloride anions in axial
positions. There is also a solvate acetonitrile molecule disordered over
two orientations around the 2-fold axis (0.25 molecules per formula
unit). Hydrogen atoms of organic ligands were placed geometrically and
refined using a rigid model. Hydrogen atoms of the disordered
acetonitrile molecule were not located. The crystal data and details of
the diffraction experiment and the structure refinement are shown in
Table S1 (Supporting Information). Selected bond distances and angles
are listed in Table S2 (Supporting Information). CCDC 910068
contains supplementary crystallographic data for this paper (complex
1b·CH3CN). These data can be obtained free of charge from The
1
1
(ArCH); 17.56 (NCMe, JCH = 131.0 Hz); 5.53 (Ni−CH3, JCH
=
129.5 Hz); minor conformer, δ 179.50 (NCMe); 153.03 (ArCF, 1JFC
1
= 248.0 Hz); 141.18 (PyCγ, JCH = 170.0 Hz); 133.21 (ArC); 130.22
(ArCH); 125.95 (ArCH); 17.40 (NCMe, JCH = 131.0 Hz); 5.76 (Ni−
1
CH3, JCH = 129.5 Hz). 19F NMR (toluene-d8/1,2-difluorobenzene, 2
°C): major conformer, δ −123.25 (m, 1F, o-F); minor conformer, δ
−122.73 (t, 1F, J = 8.6 Hz, o-F).
Activation of Catalyst 1b with MAO: Species 2b. The synthesis
was performed as described above for catalyst 1a.
1H NMR (toluene-d8/1,2-difluorobenzene, 10 °C): major conformer,
δ 7.80 (t, 1H, J = 8.0 Hz, PyHp); 7.32 (d, 2H, J = 7.9 Hz, PyHm); 3.15
(sept, 2H, J = 6.6 Hz, CH(CH3)2); 1.84 (s, 6H, NCMe); 1.21 (d, 6H, J
= 6.6 Hz, CH(CH3)2); 1.01 (d, 6H, J = 6.5 Hz, CH(CH3)2); −0.50 (s,
3H, Ni−CH3); minor conformer, δ 3.00 (sept, J = 6.5 Hz, CH(CH3)2);
1.79 (s, NCMe). 13C NMR (toluene-d8/1,2-difluorobenzene, 10 °C):
major conformer, δ 177.45 (NCMe); 143.36 (ArC); 141.36 (PyCγ,
1JCH = 169.9 Hz); 140.29 (ArC); 127.35 (ArCH); 127.20 (ArCH);
121.80 (ArCH, 1JCH = 160.0 Hz); 29.31 (CH(CH3)2, 1JCH = 127.7 Hz);
24.02 (CH(CH3)2, 1JCH = 126.5 Hz); 22.55 (CH(CH3)2, 1JCH = 126.1
Hz); 17.67 (NCMe, 1JCH = 130.5 Hz); 7.68 (Ni−CH3, 1JCH = 129.3
Hz); minor conformer, δ 143.45 (ArC); 141.32 (PyCγ); 140.41 (ArC);
127.41 (ArCH); 127.25 (ArCH); 121.46 (ArCH); 29.11 (CH(CH3)2);
23.97 (CH(CH3)2); 22.75 (CH(CH3)2); 17.78 (NCMe); 7.21 (Ni−
CH3, 1JCH = 129.3 Hz).
Activation of Catalyst 1a with AlMe3/[CPh3][B(C6F5)4]: Species
2a′. Calculated quantities of complex 1a (generally 11.4 μmol) and
[CPh3][B(C6F5)4] (1.2 equiv) were weighed in the glovebox in an NMR
tube, and the tube was closed with a septum stopper. Then, 30 equiv of
AlMe3 was injected (0.5 mL of a 0.68 M toluene solution of AlMe3)
using gastight syringes in the flow of argon upon appropriate cooling to
<0 °C. The mixture was stored for ca. 30 min at −10 °C, during which
time an oily precipitate formed in the bottom of the NMR tube. The
upper (organic) phase containing toluene, AlMe3, and Ph3CMe was
carefully removed. Into the tube containing the oily phase was injected
0.5 mL of toluene-d8/1,2-difluorobenzene (1/1) with a gastight syringe.
Addition of norbornene (4−6 equiv as a 0.45 M solution in
chlorobenzene) to the above sample (if nesessary) was performed at
20 °C, using a gastight syringe.
ASSOCIATED CONTENT
* Supporting Information
■
S
Text and figures giving NMR data and representative spectra for
complexes 2c−e, 2a′, 2b′, figures giving NMR spectra of samples
containing intermediates of the type 2 with added norbornene
and EPR spectra measured after degradation of cationic
intermediates in the presence of norbornene, and a CIF file
and tables giving X-ray data for 1b·CH3CN. This material is
AUTHOR INFORMATION
Corresponding Author
*K.P.B.: tel, +7-383-3269578; fax, +7 383 3308056; e-mail,
1H NMR (toluene-d8/1,2-difluorobenzene, 21.5 °C): major con-
former, δ 7.57 (t, 1H, J = 8.0 Hz, PyHp); 6.41 (t, 1H, J = 7.9 Hz, ArH);
1.67 (s, 3H, NCMe); −0.50 (s, Ni−CH3); minor conformer, δ 7.52 (t,
■
1H, J = 8.0 Hz, PyHp); 1.69 (s, 3H, NCMe); −0.47 (s, Ni−CH3). 13
C
NMR (toluene-d8/1,2-difluorobenzene, 21.5 °C): major conformer, δ
179.50 (NCMe); 154.92 (ArCF, 1JFC = 248.0 Hz); 149.29 (B(C6F5)4,
o-C, 1JFC = 244 Hz); 140.91 (PyCγ, 1JCH = 169.5 Hz); 140.32 (B(C6F5)4,
Notes
The authors declare no competing financial interest.
1
1
p-C, JFC = 244 Hz); 137.19 (B(C6F5)4, m-C, JFC = 243 Hz); 133.13
(ArC); 130.21 (ArCH); 126.4 (ArCH); 124.2 (ArCH); 116.96 (ArCH);
17.03 (NCMe, 1JCH = 131.2 Hz); 5.21 (Ni−CH3, 1JCH = 131.2 Hz);
ACKNOWLEDGMENTS
This work was supported by the Russian Foundation for Basic
Research (Grant No. 12-03-91159).
■
1
minor conformer, δ 179.61 (NCMe); 154.94 (ArCF, JFC = 248.0
Hz); 133.27 (ArC); 130.14 (ArCH); 116.77 (ArCH); 17.04 (NCMe,
1JCH = 131.2 Hz); 5.18 (Ni−CH3, 1JCH = 131.2 Hz).
REFERENCES
■
Activation of Catalyst 1b with AlMe3/[CPh3][B(C6F5)4]: Species
2b′. The synthesis was performed as described above for catalyst 1a.
1H NMR (toluene-d8/1,2-difluorobenzene, 10 °C): major conformer,
δ 7.66 (t, 1H, J = 7.7 Hz, PyHp); 7.19 (d, 2H, J = 7.7 Hz, PyHm); 6.48 (d,
2H, J = 6.8 Hz, ArH); 3.14 (sept, 2H, J = 6.7 Hz, CH(CH3)2); 1.74 (s,
(1) (a) Small, B. L.; Brookhart, M.; Bennett, A. M. A. J. Am. Chem. Soc.
1998, 120, 4049−4050. (b) Britovsek, G. J. P.; Gibson, V. C.; Kimberley,
B. S.; Maddox, P. J.; McTavish, S. J.; Solan, G. A.; White, A. J. P.;
Williams, D. J. Chem. Commun. 1998, 849−850. (c) Britovsek, G. J. P.;
D
dx.doi.org/10.1021/om400061p | Organometallics XXXX, XXX, XXX−XXX